{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:26:43Z","timestamp":1649194003719},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,27]]},"DOI":"10.1093\/cid\/ciz192","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T04:15:19Z","timestamp":1551413719000},"page":"2109-2111","source":"Crossref","is-referenced-by-count":1,"title":["Preventing Tuberculosis Disease: Making a Case for Enhanced Tuberculosis Screening in People Immigrating to Low-incidence Countries"],"prefix":"10.1093","volume":"69","author":[{"given":"Shereen","family":"Katrak","sequence":"first","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pennan","family":"Barry","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"2019112706210407800_CIT0001","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019112706210407800_CIT0002","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1183\/09031936.02.00261402","article-title":"European Framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group","volume":"19","author":"Broekmans","year":"2002","journal-title":"Eur Respir J"},{"key":"2019112706210407800_CIT0003","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"L\u00f6nnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"2019112706210407800_CIT0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14745\/ccdr.v44i34a01","article-title":"Tuberculosis surveillance in Canada, 2016","volume":"44","author":"Vachon","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"2019112706210407800_CIT0005","volume-title":"Reported tuberculosis in the United States, 2017","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2019112706210407800_CIT0006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence\u2014United States, 2013\u20132015","volume":"65","author":"Salinas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019112706210407800_CIT0007","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1707387","article-title":"Tuberculosis elimination in the United States\u2014the need for renewed action","volume":"377","author":"Bayer","year":"2017","journal-title":"N Engl J Med"},{"key":"2019112706210407800_CIT0008","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"2019112706210407800_CIT0009","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2019112706210407800_CIT0010","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"2019112706210407800_CIT0011","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2019112706210407800_CIT0012","year":"2016"},{"key":"2019112706210407800_CIT0013","volume-title":"Canadian tuberculosis standards","author":"Public Health Agency of Canada","year":"2014","edition":"7th ed"},{"key":"2019112706210407800_CIT0014","volume-title":"Latent tuberculosis infection updated and consolidated guidelines for programmatic management","author":"World Health Organization.","year":"2018"},{"key":"2019112706210407800_CIT0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research Team,","year":"2011","journal-title":"N Engl J Med"},{"key":"2019112706210407800_CIT0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jms.8.3.125","article-title":"Screening and the number needed to treat","volume":"8","author":"Richardson","year":"2001","journal-title":"J Med Screen"},{"key":"2019112706210407800_CIT0017","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1183\/13993003.00175-2016","article-title":"Benefit of treatment of latent tuberculosis infection in individual patients","volume":"47","author":"Dobler","year":"2016","journal-title":"Eur Respir J"},{"key":"2019112706210407800_CIT0018","author":"Centers for Disease Control and Prevention","year":"2018"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz192\/28563438\/ciz192.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/12\/2109\/31143720\/ciz192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/12\/2109\/31143720\/ciz192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:21:37Z","timestamp":1574853697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/12\/2109\/5373169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":18,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,3,11]]},"published-print":{"date-parts":[[2019,11,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz192","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,15]]},"published":{"date-parts":[[2019,3,11]]}}}